QTTB · Categories · Form 4

QTTB - SEC Form 4 insider transactions

Q32 Bio Inc. (QTTB) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for QTTB

• 81d
  SEC Form 4 filed by Violette Shelia M.

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 81d
  SEC Form 4 filed by Kalowski Lee

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 81d
  SEC Form 4 filed by Morrison Jodie Pope

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 102d
  CEO Morrison Jodie Pope sold $44,675 worth of shares (9,896 units at $4.51), decreasing direct ownership by 10% to 89,104 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 102d
  Chief Scientific Officer Violette Shelia M. sold $12,708 worth of shares (2,815 units at $4.51), decreasing direct ownership by 5% to 55,569 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 102d
  CFO and President Kalowski Lee sold $18,035 worth of shares (3,995 units at $4.51), decreasing direct ownership by 10% to 35,943 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 130d
  SEC Form 4 filed by Director Grayzel David S.

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 130d
  SEC Form 4 filed by Director Lundberg Sven Ante

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 130d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 187d
  CFO and President Kalowski Lee sold $31,395 worth of shares (9,072 units at $3.46), decreasing direct ownership by 19% to 39,938 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 187d
  CEO Morrison Jodie Pope sold $77,871 worth of shares (22,506 units at $3.46), decreasing direct ownership by 19% to 99,000 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 225d
  SEC Form 4 filed by Director Lundberg Sven Ante

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 225d
  SEC Form 4 filed by Director Iwicki Mark T

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 225d
  SEC Form 4 filed by Director Manke Isaac

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 225d
  SEC Form 4 filed by Director Xu Diyong

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 225d
  SEC Form 4 filed by Director Thistle Mary

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 225d
  SEC Form 4 filed by Director Grayzel David S.

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 225d
  SEC Form 4 filed by Director Tzianabos Arthur

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 225d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 285d
  CEO Morrison Jodie Pope sold $18,900 worth of shares (10,494 units at $1.80), decreasing direct ownership by 8% to 121,506 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 285d
  Chief Scientific Officer Violette Shelia M. sold $5,385 worth of shares (2,990 units at $1.80), decreasing direct ownership by 5% to 58,384 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 285d
  CFO and President Kalowski Lee sold $7,636 worth of shares (4,240 units at $1.80), decreasing direct ownership by 8% to 49,010 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 468d
  SEC Form 4 filed by Director Manke Isaac

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 468d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 468d
  CFO and President Kalowski Lee was granted 53,250 shares (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 468d
  SEC Form 4 filed by Director Tzianabos Arthur

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 468d
  SEC Form 4 filed by Director Xu Diyong

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 468d
  CEO Morrison Jodie Pope was granted 132,000 shares (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 468d
  SEC Form 4 filed by Director Iwicki Mark T

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 468d
  Chief Medical Officer Campagna Jason was granted 37,500 shares (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 468d
  SEC Form 4 filed by Director Grayzel David S.

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 468d
  SEC Form 4 filed by Director Thistle Mary

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 468d
  Chief Scientific Officer Violette Shelia M. was granted 37,500 shares, increasing direct ownership by 157% to 61,374 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 468d
  SEC Form 4 filed by Director Lundberg Sven Ante

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 601d
  Chief Scientific Officer Violette Shelia M. exercised 10,574 shares at a strike of $5.49, increasing direct ownership by 80% to 23,874 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 607d
  Chief Scientific Officer Violette Shelia M. exercised 13,300 shares at a strike of $3.12 (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 618d
  SEC Form 4 filed by Director Manke Isaac

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 620d
  SEC Form 4 filed by Director Lundberg Sven Ante

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 664d
  SEC Form 4 filed by Director Grayzel David S.

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 664d
  Director Tzianabos Arthur converted options into 1,095 shares and sold $6,413 worth of shares (265 units at $24.20), increasing direct ownership by 12% to 7,983 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)

Other QTTB categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends